H35.31
Nonexudative age-related macular degeneration
Clinical Classification Guidelines
Inclusion Terms
- Atrophic age-related macular degeneration
- Dry age-related macular degeneration
7th Character Definition
One of the following 7th characters is to be assigned to codes in subcategory H35.31 to designate the stage of the disease:
Medical Intelligence & Overview
Nonexudative age-related macular degeneration (ARMD), also known as dry age-related macular degeneration, is a common eye condition affecting older adults. It involves the gradual deterioration of the macula, the central part of the retina responsible for sharp, detailed vision. This form of AMD develops slowly over time and is characterized by the accumulation of small yellow deposits called drusen beneath the retina. Unlike its wet counterpart, nonexudative AMD doesn't involve abnormal blood vessel growth, making it less likely to cause sudden vision loss but still impacting vision quality gradually.
Causes & Symptoms
Clinical Causes: Aging: The primary risk factor, as the condition becomes more common with advancing age. Genetics: A family history of AMD increases the likelihood of developing the condition. Lifestyle factors: Smoking, poor diet lacking in leafy greens and antioxidants, and excessive sun exposure can contribute. Environmental influences: Exposure to cigarette smoke and certain pollutants may accelerate retinal aging. Cardiovascular conditions: High blood pressure and elevated cholesterol levels are linked to a higher risk.
Key Symptoms: Gradual loss of central vision, which may make everyday activities like reading or recognizing faces difficult. Blurring or distortion of images or objects. Distorted vision where straight lines may appear bent or wavy. Minimal or no noticeable symptoms in early stages; often detected during routine eye exams. Possible presence of yellow deposits (drusen) visible during eye examinations.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of nonexudative AMD involves comprehensive eye examinations, including retinal imaging techniques such as optical coherence tomography (OCT) and fundus photography. During these exams, ophthalmologists look for characteristic drusen, pigment changes, and thinning of the retinal layers. Regular eye check-ups are vital for early detection, especially for individuals at higher risk due to age or family history.
Treatment Protocols: Lifestyle modifications: Quitting smoking, maintaining a balanced diet rich in leafy greens, and protecting eyes from excessive sunlight. Nutritional supplements: High-dose formulations containing vitamins C and E, zinc, copper, lutein, and zeaxanthin may help slow progression in some individuals. Regular monitoring: Frequent eye examinations to track disease progression. Low vision aids: Devices such as magnifying glasses or specialized glasses can assist with daily activities as vision deteriorates. Emerging therapies: Ongoing research into treatments to preserve or restore retinal cells.
Clinical Advice & FAQs
Billing Guidance
Is H35.31 a billable ICD-10 code?
Yes, H35.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.31?
Clinical documentation must specify the nature of Nonexudative age-related macular degeneration and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
